GF
Gates Foundation Portfolio holdings
AUM
$43.5M
This Quarter Return
+44.03%
1 Year Return
+14.19%
3 Year Return
-58.08%
5 Year Return
–
10 Year Return
–
AUM
$438M
AUM Growth
–
Cap. Flow
+$438M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CureVac
CVAC
|
$254M |
| 2 |
BioNTech
BNTX
|
$85M |
| 3 |
Vir Biotechnology
VIR
|
$74M |
| 4 |
BCEL
Atreca, Inc. Class A Common Stock
BCEL
|
$23M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$1.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.59% |
| 2 | Materials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CureVac
CVAC
$1.21B
| $254M | 58.02% | +3,134,780 | New | +$254M |
|
|
2
BioNTech
BNTX
$24B
| $85M | 19.42% | +1,038,674 | New | +$85M |
|
|
3
Vir Biotechnology
VIR
$686M
| $74M | 16.9% | +2,777,777 | New | +$74M |
|
|
BCEL
4
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $23M | 5.25% | +1,396,644 | New | +$23M |
|
|
AMRS
5
DELISTED
Amyris Inc.
AMRS
| $1.8M | 0.41% | +292,398 | New | +$1.8M |
|